Ketamine Recruiting Phase 2 Trials for Refractory Cancer Pain / Ketamine Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03362073Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients